185 related articles for article (PubMed ID: 23573823)
21. Myeloproliferative disorders.
Schwartz SI
Ann Surg; 1975 Oct; 182(4):464-71. PubMed ID: 1058648
[TBL] [Abstract][Full Text] [Related]
22. Splenectomy in myeloid metaplasia.
Cabot EB; Brennan MF; Rosenthal DS; Wilson RE
Ann Surg; 1978 Jan; 187(1):24-30. PubMed ID: 74243
[TBL] [Abstract][Full Text] [Related]
23. Splenectomy for massive splenomegaly.
Coon WW
Surg Gynecol Obstet; 1989 Sep; 169(3):235-7. PubMed ID: 2772794
[TBL] [Abstract][Full Text] [Related]
24. Splenectomy in patients with mixed myelodysplastic/myeloproliferative disease.
Kraemer D; Rüdiger T; Reimer P; Müller-Hermelink HK; Wilhelm M
Ann Hematol; 2002 Jun; 81(6):308-11. PubMed ID: 12107559
[TBL] [Abstract][Full Text] [Related]
25. [Splenectomy in osteomyelofibrosis. Indications and outcome].
Böhner H; Rötzscher VM; Tirier C; Heit W; Greiner J
Chirurg; 1996 Oct; 67(10):1016-9. PubMed ID: 9011420
[TBL] [Abstract][Full Text] [Related]
26. Splenectomy for patients with myelofibrosis with myeloid metaplasia: pretreatment variables and outcome prediction.
Barosi G; Ambrosetti A; Buratti A; Finelli C; Liberato NL; Quaglini S; Ricetti MM; Visani G; Tura S; Ascari E
Leukemia; 1993 Feb; 7(2):200-6. PubMed ID: 8426474
[TBL] [Abstract][Full Text] [Related]
27. Refining the selection criteria for laparoscopic versus open splenectomy for splenomegaly.
Feldman LS; Demyttenaere SV; Polyhronopoulos GN; Fried GM
J Laparoendosc Adv Surg Tech A; 2008 Feb; 18(1):13-9. PubMed ID: 18266568
[TBL] [Abstract][Full Text] [Related]
28. Outcomes following splenectomy in patients with myeloid neoplasms.
Rialon KL; Speicher PJ; Ceppa EP; Rendell VR; Vaslef SN; Beaven A; Tyler DS; Blazer DG
J Surg Oncol; 2015 Mar; 111(4):389-95. PubMed ID: 25488568
[TBL] [Abstract][Full Text] [Related]
29. Portal vein thrombosis following splenectomy for hematologic disease: prospective study with Doppler color flow imaging.
Chaffanjon PC; Brichon PY; Ranchoup Y; Gressin R; Sotto JJ
World J Surg; 1998 Oct; 22(10):1082-6. PubMed ID: 9747171
[TBL] [Abstract][Full Text] [Related]
30. Allogeneic Transplantation for Patients With Advanced Myelofibrosis: Splenomegaly and High Serum LDH are Adverse Risk Factors for Successful Engraftment.
Gergis U; Kuriakose E; Shore T; Mayer S; Mark T; Pearse R; Schuster M; Feldman E; Roboz G; Ritchie E; Scandura J; Wang H; Zhou XK; Silver RT; van Besien K
Clin Lymphoma Myeloma Leuk; 2016 May; 16(5):297-303. PubMed ID: 27025789
[TBL] [Abstract][Full Text] [Related]
31. [Portal hypertension after splenectomy for myeloid splenomegaly].
Perreau P; Joubaud F; Gardais J; Simard C
Sem Hop; 1972 Jan; 48(5):355-9. PubMed ID: 4339308
[No Abstract] [Full Text] [Related]
32. Modern management of splenomegaly in patients with myelofibrosis.
Tremblay D; Schwartz M; Bakst R; Patel R; Schiano T; Kremyanskaya M; Hoffman R; Mascarenhas J
Ann Hematol; 2020 Jul; 99(7):1441-1451. PubMed ID: 32417942
[TBL] [Abstract][Full Text] [Related]
33. Splenectomy for myelofibrosis.
Järvinen H; Kivilaakso E; Ikkala E; Vuopio P; Hästbacka J
Ann Clin Res; 1982 Apr; 14(2):66-71. PubMed ID: 7149614
[TBL] [Abstract][Full Text] [Related]
34. [Splenectomy in idiopathic thrombopenic purpura and in myelofibrosis. A retrospective study of platelet increase, hemorrhagic complications and mortality].
Hellström P; Ogier C; Askergren J; Sundblad R; Reizenstein P
Minerva Chir; 1981 Sep; 36(17):1065-8. PubMed ID: 7197336
[TBL] [Abstract][Full Text] [Related]
35. Patient characteristics and outcomes in adolescents and young adults with classical Philadelphia chromosome-negative myeloproliferative neoplasms.
Boddu P; Masarova L; Verstovsek S; Strati P; Kantarjian H; Cortes J; Estrov Z; Pierce S; Pemmaraju N
Ann Hematol; 2018 Jan; 97(1):109-121. PubMed ID: 29143068
[TBL] [Abstract][Full Text] [Related]
36. Splenectomy for massive splenomegaly.
Sharp P; Grace CS; Rozenberg MC; Ham JM
Aust N Z J Surg; 1985 Oct; 55(5):489-92. PubMed ID: 3868413
[TBL] [Abstract][Full Text] [Related]
37. Patients with post-essential thrombocythemia and post-polycythemia vera differ from patients with primary myelofibrosis.
Masarova L; Bose P; Daver N; Pemmaraju N; Newberry KJ; Manshouri T; Cortes J; Kantarjian HM; Verstovsek S
Leuk Res; 2017 Aug; 59():110-116. PubMed ID: 28601551
[TBL] [Abstract][Full Text] [Related]
38. Still a role for surgery as first-line therapy of splenic marginal zone lymphoma? Results of a prospective observational study.
Pata G; Bartoli M; Damiani E; Solari S; Anastasia A; Pagani C; Tucci A
Int J Surg; 2017 May; 41():143-149. PubMed ID: 28366762
[TBL] [Abstract][Full Text] [Related]
39. Laparoscopic splenectomy for treatment of splenic marginal zone lymphoma.
Wu Z; Zhou J; Wang X; Li YB; Niu T; Peng B
World J Gastroenterol; 2013 Jun; 19(24):3854-60. PubMed ID: 23840125
[TBL] [Abstract][Full Text] [Related]
40. An atypical myeloproliferative disorder with high thrombotic risk and slow disease progression.
Barosi G; Buratti A; Costa A; Liberato LN; Balduini C; Cazzola M; Rosti V; Magrini U; Ascari E
Cancer; 1991 Nov; 68(10):2310-8. PubMed ID: 1913467
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
